Skip to main content
. 1998 Feb;72(2):1005–1012. doi: 10.1128/jvi.72.2.1005-1012.1998

TABLE 1.

Transcription mapping of KSHV in BC-1 cells with and without TPA

Probe no. ORFs encoded on probe Position (bp) Probe size (kb) mRNAs (kb) identified in BC-1a
Transcription class
Without TPA induction With TPA induction
1 K1,4 (v-CBP), 6 TR (366 bp) 6.715 6.0+ 6.0 II
1–6349 4.0 III
3.0 III
1.8 III
1.0 III
2 7, 8, 9, 10, 11 6900–16600 9.7 − 7.0 III
6.0 III
2.5 III
1.0 III
3 11, K2 (v-IL-6), 2 (DHFR), K3 (IEI) 16200–19700 3.5 8.0 III
6.0 III
3.1 III
2.0 III
1.0 ++ (K2[v-IL-6]) 1.0 II
4 K3 (IE1), 70 (TS), 19130–23906 4.776 4.0 III
K4 (v-MIP-II), K4.1 2.5 III
2.3+ 2.3 II
2.0 III
1.5 III
0.8 ++ (K4 [vMIP-II]) 0.8 II
5 K5 (IE1), K6 (v-MIP-I), 24839–28888 4.049 4.0 + 4.0 II
 K7 (nut-1) 1.3 + 1.3 II
1.1 +++ (T1.1/nut1) 1.1 II
6 K7 (nut-1) 28889–29676 0.787 9.0 III
1.1 ++++ (T1.1/nut-1) 1.1 II
7 16 (v-Bc12), 17 29677–30840 1.163 − 9.0 III
7.0 III
3.5 III
2.0 III
1.0 III
8 17 30841–32361 1.52 − 7.0 III
6.0 III
3.5 III
2.0 III
1.0 III
9 17, 18, 19 32362–34401 2.039 − 7.0 III
6.0 III
1.0 III
10 19, 20, 21 34021–36882 2.861 − 7.0 III
6.0 III
11 21, 22, 23, 24, 25 36883–43171 6.288 − 7.0 III
6.0 III
3.0 III
12 25, 26 43172–47193 4.021 − 7.0 III
2.0 III
13 26, 27, 28, 29b, 30 47517–50637 3.12 − 7.0 III
2.0 III
14 30, 31, 32, 33, 29a, 34, 35 50638–55722 5.084 − 8.0 III
6.0 III
3.0 III
15 34, 35 55269–55819 0.55 − 4.5 III
3.0 III
1.1 III
16 36, 37, 38, 39, 40, 41, 42 55820–62901 7.081 4.5 III
3.0 III
2.5 + 2.5 II
1.4 III
0.5 III
17 42, 43 62902–63403 0.501 − 9.0 III
6.0 III
4.5 III
3.0 III
2.5 III
1.4 III
18 43 63404–63793 0.389 − 9.0 III
4.5 III
3.0 III
19 43, 44 64037–66502 2.465 6.0 + 6.0 II
4.5 III
3.0 III
2.7 III
20 44, 45 66503–68324 1.821 9.0 III
4.0 III
2.5+ 2.5 II
1.5 +++ 1.5 II
21 45, 46, 47, 48, 49 68325–72191 3.866 − 8.0 III
2.5 III
1.5 III
0.8 III
22 49, 50, K8, K8.1, 52 72192–77087 4.895 7.0 III
4.0 III
1.8 + 1.8 II
1.5 + 1.5 II
23 52, 53, 54, 55, 56 77088–81046 3.958 − 3.0 III
2.0 III
1.3 III
24 56, 57 81047–83278 2.231 2.0 + 2.0 II
25 57, K9 (v-IRF1), K10 83279–86279 3.0 2.0 III
1.5 ++ (v-IRF) 1.5 II
26 K10 86879–90158 3.279 3.0 III
2.0 + 2.0 III
1.5 III
27 K10.1, K11 90159–92110 1.951 2.0 + 2.0 II
28 K11 92111–92468 0.357 4.5 III
3.0 III
2.0 + 2.0 II
29 K11, 58, 59 60, 61 92665–99864 7.199 6.0 III
3.0 III
2.0 + 2.0 II
30 61, 62, 63 99865–101232 1.367 − 2.0 III
1.7 III
31 62, 63, 64 100784–104075 3.291 − 2.0 III
1.7 III
32 64 104076–107008 2.932 − 5.0 III
3.0 III
2.0 III
1.7 III
1.2 III
33 64, 65, 66, 67, 67.5, 68 107940–115051 7.111 − 7.0 III
5.0 III
4.0 III
2.5 III
1.2 III
34 68 115052–115707 0.655 − 9.0 III
7.0 III
6.0 III
4.0 III
35 68, 69, K12 (kaposin) 115708–120725 5.017 4.0 III
0.7 ++++ (T0.7/kaposin) 0.7 II
36 K13 (v-FLIP) 120601–122590 1.989 6.0 + (v-FLIP, v-Cyc, LANA) 6.0 I
2.0 + (v-FLIP, v-Cyc) 2.0 I
37 K13 (v-FLIP), 122591–127392 4.801 6.0 ++ (v-FLIP, v-Cyc, LANA) 6.0 I
72 (v-Cyc), 73 (LANA) 2.0 ++ (v-FLIP, v-Cyc) 2.0 I
38 72 (v-Cyc) 122792–123565 0.773 6.0 ++ (v-FLIP, v-Cyc, LANA) 6.0 I
2.0 ++ (v-FLIP, v-Cyc) 2.0 I
39 K14, 74 (V-GCR), 75 127393–133381 5.988 6.0 + (v-FLIP, v,Cyc, LANA) 6.0 I
4.5 +++ 4.5 I
3.0 III
2.5 III
2.0 + (v-FLIP, v-Cyc) 2.0 I
40 K14 (v-Adh) 127882–128928 1.046 4.5 + 4.5 I
2.5 III
1.5 III
1.2 III
41 74 (v-GCR) 129513–129985 0.472 − 9.0 III
2.5 III
42 K15 135976–136278 0.302 − 9.0 III
6.0 III
a

Specific genes identified with specific sequence probes are indicated in paretheses. Relative transcription in BC-1 without TPA: −, none; +, low; ++, moderate; +++, high; ++++, very high. For abbreviations, see the legend to Fig. 1.